Embracing Highly Effective Obesity Therapies to Improve Cancer Treatment and Survivorship

This Viewpoint examines the underutilization of glucagon-like peptide-1 receptor agonists and bariatric surgery in survivors of cancer.

Corresponding Author: Ryan Howard, MD, MS, DABOM, Department of Surgery, Section of General Surgery, Division of Minimally Invasive Surgery, 2924B Taubman Center, SPC 5331, University of Michigan, 1500 E Medical Center Dr, Ann Arbor, MI 48109-5331 (rhow@med.umich.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.